Full Press Release Details
Zymeworks to Present on Clinical and Preclinical Programs at Multiple Upcoming Medical Conferences.
ZYME
Zymeworks to Present on Clinical and Preclinical Programs at Multiple Upcoming Medical Conferences
Key Takeaway: Zymeworks to Present on Clinical and Preclinical Programs at Multiple Upcoming Medical Conferences
Price reaction · baseline $6.37 (2023-09-26 close) · hit after-hours · clean, no other ZYME news in the window
day 0 close · peak
-2.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers